Drug Discovery & Pharmaceuticals

RSS

Key research takeaways from ECCMID 2019

This article aims to provide a brief overview of the key themes of the 29th ECCMID conference and update readers on current research projects.

From ESCMID 19 Apr 2019

Microfluidic-based drug screening chip identifies antibiotic interactions in eight hours

A KAIST research team developed a microfluidic-based drug screening chip that identifies synergistic interactions between two antibiotics in eight hours.

19 Apr 2019

Scientists enter research collaboration to find a cure for cancer

Cancer is a disease that afflicts an alarming number of people, with one in two being diagnosed with a type of cancer during their lifetime.

17 Apr 2019

Researchers create new small molecules that may combat equine encephalitis viruses

Viruses without a preventative vaccine or treatment option pose a looming threat. But for viruses in this category that have already been weaponized and are recognized as human biothreats by the Centers for Disease Control and Prevention, it's a race to find a cure.

17 Apr 2019

Researchers discover new broad-spectrum antibiotic that contains arsenic

Antibiotic resistance has been called one of the biggest public health threats of our time. There is a pressing need for new and novel antibiotics to combat the rise in antibiotic-resistant bacteria worldwide.

16 Apr 2019

Leica Microsystems receives FDA De Novo clearance for blue light fluorescence module

Leica Microsystems has received DeNovo clearance from the FDA to market its FL400 surgical microscope filter in the United States for characterization of tumor tissue in neurosurgery.

From Leica Microsystems GmbH 15 Apr 2019

Hundreds of new anti-cancer drug targets identified using CRISPR

A team of scientists from the Wellcome Sanger Institute have identified the genes that are essential for the survival of thirty types of cancer cells.

11 Apr 2019

GARDP forms multi-actor partnerships to discover new antibiotics

Multi-actor partnership tests natural products and compound libraries for antibacterial activity Discovery efforts will focus on World Health Organization's priority pathogens The Global Antibiotic Research and Development Partnership is partnering with Calibr, the Helmholtz Centre for Infection Research, in particular its location Helmholtz-Institute for Pharmaceutical Research Saarland, and the University of Queensland's Community for Open Antimicrobial Drug Discovery in its efforts to develop and ensure new antibiotics are globally available to all patients who need them.

11 Apr 2019

New molecule could help fight type 2 diabetes and non-alcoholic fatty liver disease

A new molecule -EPB-53-, could help fight type 2 diabetes and the non-alcoholic fatty liver disease, according to a new study led by the team of Manuel Vázquez-Carrera, from the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and the Diabetes and Associated Metabolic Diseases Networking Biomedical Research Center.

10 Apr 2019

Bio-Rad launches new isotype-specific secondary antibodies

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced the launch of its isotype-specific secondary antibodies.

From Bio-Rad Laboratories 10 Apr 2019

Alcohol, Cannabis and Other Drugs: A Pharmacological Evaluation

Understanding the interactions between alcohol and cannabis can provide researchers, clinicians and other HCPs with important information on the severity of their side effects.

10 Apr 2019

Don't Believe the Hemp: UHPLC Analysis of Hemp Seed Oils

Despite the popularity of hemp seed oil products, there are currently no standardized analysis techniques. To this end, researchers have been exploring the use of HPLC-MS for cannabinoid profiling of hemp.

10 Apr 2019

Researchers develop new method for identifying compounds that prevent aging

Researchers at Karolinska Institutet in Sweden have developed a new method for identifying compounds that prevent aging.

9 Apr 2019

Synthetic antibody rapidly prevents Zika infection in mice and non-human primates

A DNA-encoded monoclonal antibody prevents Zika infection in mice and non-human primates, researchers report April 5 in the journal Molecular Therapy.

8 Apr 2019

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

On April 8, Celltrion and the Canada-based iProgen Biotech Inc. announced to agree to partner for the development of novel ADCs against validated antibody targets, including HER2 and CD20.

8 Apr 2019

Inauguration of NIDD, the Neuroimmunology Drug Development Summit

NIDD is the industry’s first meeting dedicated to targeting neuroimmunological mechanisms in order to develop clinically efficacious therapeutics.

From Neuroimmunology Drug Development 5 Apr 2019

Researchers isolate compound that kills drug-resistant fungi from ant microbiota

Antimicrobial and antifungal resistance, which describe the ability of bacteria and other pathogens to resist the effects of drugs to which they were once sensitive, is a major public health problem worldwide.

5 Apr 2019

Researchers use metal-free catalyst to synthesize ketone from aldehyde

Ketones are important organic compounds found in a variety of pharmaceuticals, agrochemicals, and natural products.

4 Apr 2019

Scientists develop new accurate computational method to enhance drug target stability

Scientists from the Moscow Institute of Physics and Technology, the Skolkovo Institute of Science and Technology, and the University of Southern California have developed a new computational method for the design of thermally stable G protein-coupled receptors that are of great help in creating new drugs.

30 Mar 2019

Young scientists develop cheap and simple catalyst system for organic synthesis

The removal of carboxyl groups and the release of alkyl radical fragments from the tight binding of carboxyl groups are one of the most interesting and promising directions in organic synthesis, especially in the field of new drug synthesis.

30 Mar 2019

Drug Discovery & Pharmaceuticals

Key research takeaways from ECCMID 2019

Microfluidic-based drug screening chip identifies antibiotic interactions in eight hours

Scientists enter research collaboration to find a cure for cancer

Researchers create new small molecules that may combat equine encephalitis viruses

Researchers discover new broad-spectrum antibiotic that contains arsenic

Leica Microsystems receives FDA De Novo clearance for blue light fluorescence module

Hundreds of new anti-cancer drug targets identified using CRISPR

GARDP forms multi-actor partnerships to discover new antibiotics

New molecule could help fight type 2 diabetes and non-alcoholic fatty liver disease

Bio-Rad launches new isotype-specific secondary antibodies

Alcohol, Cannabis and Other Drugs: A Pharmacological Evaluation

Don't Believe the Hemp: UHPLC Analysis of Hemp Seed Oils

Researchers develop new method for identifying compounds that prevent aging

Synthetic antibody rapidly prevents Zika infection in mice and non-human primates

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

Inauguration of NIDD, the Neuroimmunology Drug Development Summit

Researchers isolate compound that kills drug-resistant fungi from ant microbiota

Researchers use metal-free catalyst to synthesize ketone from aldehyde

Scientists develop new accurate computational method to enhance drug target stability

Young scientists develop cheap and simple catalyst system for organic synthesis

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest Life Science News